Compass Minerals International Inc. press release

CLASS ACTION UPDATE for CNTA, ARGO and CMP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

2022-11-09

NYSE - New York Stock Exchange · Salt · Potash · Magnesium · United States

NEW YORK, NY / ACCESSWIRE / November 8, 2022 /Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

CNTA Shareholders Click Here: https://www.zlk.com/pslra-1/centessa-pharmaceuticals-loss-submission-form?prid=33487&wire=1 ARGO Shareholders Click Here: https://www.zlk.com/pslra-1/argo-group-loss-submission-form?prid=33487&wire=1 CMP Shareholders Click Here: https://www.zlk.com/pslra-1/compass-minerals-loss-submission-form?prid=33487&wire=1

ADDITIONAL INFORMATION BELOW

Centessa Pharmaceuticals plc (NASDAQ:CNTA)

This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Centessa American Depositary Shares pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about May 28, 2021; and/or (b) Centessa securities between May 28, 2021 and June 1, 2022. Lead Plaintiff Deadline : November 28, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/centessa-pharmaceuticals-loss-submission-form?prid=33487&wire=1

According to the filed complaint, (i) the Company's product, lixivaptan, was less safe than defendants had represented; (ii) defendants overstated lixivaptan's clinical and commercial prospects; (iii) another Centessa product, ZF874, was less safe than defendants had represented; (iv) defendants overstated ZF874's clinical and commercial prospects while downplaying the drug's safety issues; and (v) as a result, documents issued in connection with Centessa's initial public offering and the Company's public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

Argo Group International Holdings, Ltd. (NYSE:ARGO)

This lawsuit is on behalf of investors that purchased or otherwise acquired Argo common stock between February 13, 2018 and August 9, 2022. Lead Plaintiff Deadline : December 20, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/argo-group-loss-submission-form?prid=33487&wire=1

According to the filed complaint, (1) Argo's reserves were wholly inadequate and its underwriting standards were not prudent as was represented; (ii) Argo had dramatically changed its underwriting policies on certain U.S. construction contracts as far back as 2018; and (iii) these policies were underwritten outside of the Company's "core" business including in certain states and for certain exposures that were far riskier than investors understood and that the Company no longer would service moving forward.

Compass Minerals International, Inc. (NYSE:CMP)

This lawsuit is on behalf of all purchasers of Compass Minerals common stock between October 31, 2017 and November 18, 2018, inclusive. Lead Plaintiff Deadline : December 20, 2022 TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/compass-minerals-loss-submission-form?prid=33487&wire=1

According to the filed complaint, 1) costs at the Company's salt mine in Goderich, Ontario were increasing rather than decreasing; 2) defendants had misrepresented the amount of salt the Company was able to produce at Goderich using the new continuous mining and continuous haulage equipment; and 3) the known and ongoing production shortfalls the Company was experiencing were reasonably expected to reduce its future operating income.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff.Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Eduard Korsinsky, Esq. 55 Broadway, 10th Floor New York, NY 10006 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com: https://www.accesswire.com/724705/CLASS-ACTION-UPDATE-for-CNTA-ARGO-and-CMP-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders